Clinical trials · California
Recurrent Meningioma clinical trials in California
We’re tracking 6 recruiting recurrent meningioma studies with a site in California — including Phase 2 studies, each written for real people, not researchers.
Recruiting studies in California
- NCT02847559RecruitingPhase 2
Electric field therapy plus bevacizumab for recurrent meningioma
This trial tests whether using an electric-field treatment delivered to the brain, along with a cancer medicine called bevacizumab, can shrink or control recurrent (returned) or progressive grade 2–3 meningioma. It’s designed for tumors that can’t be fully cured with surgery and standard treatments, and aims to slow tumor growth and improve outcomes.
Santa Monica, CaliforniaAges 18 years+ - NCT06557512Recruiting
Targeted radiation after surgery for aggressive or recurring meningioma
This trial tests a precise, low-dose radiation treatment (hypofractionated stereotactic radiosurgery) given after surgery for certain high-risk or returning meningiomas. It aims to lower the chance of the tumor coming back with fewer side effects.
San Francisco, CaliforniaAges 18 years+ - NCT02523014RecruitingPhase 2
Drug combo for meningioma that keeps growing despite treatment
This Phase 2 trial tests several targeted medicines (given together or by specific assignment) for meningiomas inside the brain that are progressing or not fully removed after surgery. It may help slow the tumor’s growth and improve symptoms by blocking tumor growth pathways.
Antioch, CaliforniaAges 18 years+ - NCT05023018RecruitingPhase 2
NEO100 for recurrent or progressive high-grade meningioma
This trial studies NEO100, a treatment for adults and children (age 12+) with Grade II or III meningioma that has come back or kept growing after surgery and radiation. It may help shrink tumors or slow growth when standard options have not worked well enough.
Los Angeles, CaliforniaAges 12 years+ - NCT07533942RecruitingPhase 2
Testing JZP3507 for Recurrent Grade 2 or 3 Brain Tumors
This study tests a new drug called JZP3507 for people with meningioma (a type of brain tumor, grades 2 or 3) that has come back or grown despite previous treatment. The goal is to see if this medication can slow or shrink the tumor.
San Francisco, CaliforniaAges 18 years+ - NCT04427384Recruiting
Brain tumor patients treated with GammaTiles registry
This study is a patient registry for people with brain tumors who had surgery to remove as much as safely possible and then had GammaTiles placed. It mainly collects information and follow-up imaging to understand how patients do after the treatment.
Castro Valley, CaliforniaAges Any age
Where these studies are running in California
Institutions with a site for the recruiting recurrent meningioma studies listed above.
- California Pacific Medical Center · 2 studies
- Eden Medical Center · 2 studies
- Sutter Health · 2 studies
- University of California, San Francisco · 2 studies
- Alta Bates Summit Medical Center
- Cedars-Sinai Medical Center
- Desert Regional Medical Center
- Kaiser Permanente Deer Valley Medical Center
What taking part in a recurrent meningioma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Common questions
- Are there recurrent meningioma clinical trials in California?
- Yes. We're currently tracking 6 recruiting recurrent meningioma studies with a site in California, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a recurrent meningioma study in California?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in California to take part?
- Not necessarily. These studies have a site in California, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a recurrent meningioma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New recurrent meningioma studies open in California regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.